APA

Lees O., Ramzaoui S., Gilbert D., Borsa F., Humbert G., Leblanc D., Lagarde M. & Tron F. (19930629). The impaired in vitro production of interleukin-2 in HIV infection is negatively correlated to the number of circulating CD4+DR+ T cells and is reversed by allowing T cells to rest in culture: arguments for in vivo CD4+ T cell activation. : Clinical immunology and immunopathology.

Chicago

Lees O, Ramzaoui S, Gilbert D, Borsa F, Humbert G, Leblanc D, Lagarde M and Tron F. 19930629. The impaired in vitro production of interleukin-2 in HIV infection is negatively correlated to the number of circulating CD4+DR+ T cells and is reversed by allowing T cells to rest in culture: arguments for in vivo CD4+ T cell activation. : Clinical immunology and immunopathology.

Harvard

Lees O., Ramzaoui S., Gilbert D., Borsa F., Humbert G., Leblanc D., Lagarde M. and Tron F. (19930629). The impaired in vitro production of interleukin-2 in HIV infection is negatively correlated to the number of circulating CD4+DR+ T cells and is reversed by allowing T cells to rest in culture: arguments for in vivo CD4+ T cell activation. : Clinical immunology and immunopathology.

MLA

Lees O, Ramzaoui S, Gilbert D, Borsa F, Humbert G, Leblanc D, Lagarde M and Tron F. The impaired in vitro production of interleukin-2 in HIV infection is negatively correlated to the number of circulating CD4+DR+ T cells and is reversed by allowing T cells to rest in culture: arguments for in vivo CD4+ T cell activation. : Clinical immunology and immunopathology. 19930629.